Sygnature Discovery
Dr. Hayley Butler also joins the company from RedX Pharma where she worked on oncology and infection projects.
In her new position as a principal scientist she looks forward “to providing DMPK project support and expertise to both fully integrated and stand-alone client projects, alongside further developing the PK and PK/PD capabilities within the department.”